<DOC>
	<DOC>NCT00002292</DOC>
	<brief_summary>To compare parenteral versus inhaled pentamidine in patients with documented Pneumocystis carinii pneumonia (PCP) with AIDS.</brief_summary>
	<brief_title>A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>Pneumonia, Pneumocystis</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<criteria>Exclusion Criteria Coexisting Condition: Patients with the following are excluded: Previous history of adverse reaction to pentamidine. History of asthma. Pulmonary Kaposi's sarcoma. Patients with the following are excluded: Previous history of adverse reaction to pentamidine. History of asthma. Pulmonary Kaposi's sarcoma. Inability to understand the consent procedure. All patients hospitalized at CedarsSinai Medical Center with AIDS and possible Pneumocystis carinii pneumonia (PCP) will be eligible. Patients with HIV antibody or AIDS and a clinical presentation suggesting PCP are eligible.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 1989</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia, Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Injections, Intravenous</keyword>
	<keyword>Administration, Inhalation</keyword>
	<keyword>Aerosols</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>